SENSICARDIAC vs AVIEW

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

AVIEW

by Coreline Soft Co.

AI Verdict

SENSICARDIAC specializes in real-time heart murmur detection and classification using electronic stethoscopes, aiding in early diagnosis and reducing referrals. AVIEW, conversely, focuses on analyzing CT scans for the early detection, diagnosis, and monitoring of lung conditions and coronary artery calcification. While both contribute to cardiac health assessment, SENSICARDIAC is an auscultation-based screening tool, whereas AVIEW provides imaging-based diagnostics for structural conditions.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your primary need is real-time, AI-assisted heart murmur detection and classification during patient auscultation, particularly in remote or primary care settings. This tool is ideal for physicians seeking to quickly screen for pathological murmurs using an electronic stethoscope, aiming to reduce unnecessary specialist referrals and enhance initial diagnostic accuracy.

View SENSICARDIAC →

Choose AVIEW if…

Choose AVIEW if your practice requires comprehensive AI-driven analysis of CT scans for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification. This platform is best suited for radiologists and pulmonologists who need detailed quantitative data, 3D visualizations, and workflow automation for complex medical imaging interpretation.

View AVIEW →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC	AVIEW
Pricing	Unknown	Subscription; one-off payment
Deployment	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.	Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC features a 'guided auscultation process' and 'real-time analysis,' suggesting a streamlined and intuitive user experience for its specific function of heart murmur detection. While AVIEW offers workflow automation, SENSICARDIAC's direct guidance for a clinical examination task points to a more immediately usable interface for its primary users.

Clinical Value

AVIEW

AVIEW offers comprehensive AI solutions for the early detection, diagnosis, and monitoring of multiple high-impact conditions, including lung cancer, COPD, and coronary artery calcification, from CT scans. Its ability to provide quantitative analysis across several critical disease areas suggests a broader and potentially higher clinical impact compared to SENSICARDIAC's focused heart murmur detection.

Pricing & Value

AVIEW

SENSICARDIAC's pricing is not publicly available, making it difficult to assess its value proposition. AVIEW, while not providing specific figures, at least outlines its pricing model (subscription or one-off payment, based on installations and users), offering more transparency on how costs are structured.

Enterprise Readiness

AVIEW

AVIEW demonstrates stronger enterprise readiness through its flexible deployment options (cloud, hybrid, local hardware, virtualized) and explicit integration with standard radiology enterprise systems like PACS/RIS/CIS. While SENSICARDIAC offers cloud/desktop deployment and a BAA, AVIEW's broader integration capabilities are crucial for large-scale healthcare environments.

Innovation

SENSICARDIAC

SENSICARDIAC's innovation lies in its real-time, AI-powered heart murmur detection integrated with live stethoscope streaming, directly enhancing a traditionally subjective physical examination at the point of care. While AVIEW offers advanced AI for imaging analysis, SENSICARDIAC's application to live auscultation represents a novel approach to a fundamental clinical interaction.

Support & Docs

Tie

Neither the provided structured facts nor readily available public web searches offer specific details regarding the depth, availability, or quality of support and documentation for either SENSICARDIAC or AVIEW. Both companies generally mention support and training, but without further information, a distinction cannot be made.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC	AVIEW
Name	SENSICARDIAC	AVIEW
Company	DIACOUSTIC MEDICAL (PTY)	Coreline Soft Co.
Primary Function	AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological, aiding physicians in diagnosis and reducing unnecessary referrals.	AI platform offering comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows.
Primary Categories	Cardiology AI, Telehealth & Virtual Care, Wearables & Remote Monitoring (RPM)	Cardiology AI, Oncology AI, Radiology & Imaging AI
Target Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Pulmonology, Radiology
Key AI Application	AI-powered heart murmur detection and classification (pathological/physiological) from electronic stethoscope data.	AI-powered lung nodule detection and characterization, emphysema quantification, and coronary artery calcium (CAC) scoring from CT scans.

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and AVIEW.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do SENSICARDIAC and AVIEW integrate into existing clinical workflows and what specific clinical problems do they address for different specialties?

SENSICARDIAC integrates with electronic stethoscopes to provide real-time AI-powered heart murmur detection, classifying murmurs as pathological or physiological, which aids cardiologists, internal medicine physicians, and pediatricians in diagnosis and can reduce unnecessary referrals. AVIEW integrates with PACS/RIS/CIS to streamline radiology workflows by offering AI-powered solutions for early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, primarily benefiting cardiologists, pulmonologists, and radiologists.

What is the diagnostic accuracy or sensitivity of each tool for the conditions they target?

SENSICARDIAC's AI-powered murmur detection has a reported accuracy above 95 percent, with a sensitivity of 84% and specificity of 94% relative to echo, classifying murmurs as dangerous pathological (Class I) or innocent physiological (Class III) based on a large validated database. AVIEW provides AI-powered detection and characterization of lung nodules, emphysema quantification, and coronary artery calcium scoring from CT scans, enhancing diagnostic precision, though specific overall accuracy, sensitivity, and specificity metrics are not detailed in the provided information.

What is the expected learning curve for physicians and their teams to effectively use each system?

SENSICARDIAC features a guided auscultation process, suggesting a straightforward learning curve for physicians and trained personnel using electronic stethoscopes. AVIEW, as an AI platform for medical imaging, aims to streamline radiology workflows through automation and integration, which typically implies some initial training, but the goal is to reduce friction and simplify the user experience.

Beyond standard compliance, what advanced security features or audit trail capabilities do these tools offer to protect patient data and ensure accountability?

SENSICARDIAC's description does not explicitly detail security features beyond HIPAA compliance. AVIEW offers features like follow-up registration and nodule matching for serial CT scans, which inherently provide a level of auditability for patient data over time.

How easily can these solutions be scaled for multi-site hospital systems or large practices?

SENSICARDIAC is a cloud-based service, which inherently supports remote access and scalability for multi-site cardiac care. AVIEW offers flexible deployment options including cloud-based, hybrid solutions, or local deployment on dedicated hardware or virtualized environments, providing versatility for various multi-site and enterprise-level rollouts.

What is the expected time-to-value and how quickly can a practice expect to see tangible benefits and efficiency gains after implementing each tool?

SENSICARDIAC offers real-time analysis and immediate murmur classification, aiming to reduce unnecessary referrals and expedite diagnostic pathways, suggesting a rapid time-to-value through quicker clinical decisions. AVIEW is designed to streamline radiology workflows, enhance diagnostic precision, and automate tasks like segmentation and scoring, which should lead to significant efficiency gains and a faster realization of value in CT scan interpretation.